Japan

Kirin Holdings And Immunosens Launch Joint Development Of Immune Self Testing Service

Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Ser...

 February 11, 2026 | News

Fujitsu Japan And JMDC Partner To Accelerate Data Driven Healthcare In Japan

Fujitsu Japan Limited and JMDC Inc. announced the commencement of a collaboration aimed at advancing medical care and contributing to the establishment of ...

 February 11, 2026 | News

Eisai And Henlius Sign Exclusive Japan Commercialisation Deal For Anti PD 1 Antibody Serplulimab

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO:&nbs...

 February 10, 2026 | News

Telix Pharmaceuticals Limited Doses First Patient In Japan Phase 3 Study Of Illuccix For Prostate Cancer Imaging

Telix Pharmaceuticals Limited  announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for ...

 January 30, 2026 | News

Japan Tissue Engineering Co Secures National Insurance Reimbursement For JACC In Knee Osteoarthritis

-Japan Tissue Engineering Co., Ltd.(J-TEC) announced that JACC, its autologous cultured cartilage product, has been granted approval by Japan&rsqu...

 January 28, 2026 | News

Japan’s Daiichi Sankyo Strengthens Oncology Commitment With Toronto Headquarters

Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines Daiichi Sankyo (TSE: 4568)...

 January 23, 2026 | News

Fujifilm Corporation Completes Major Bio CDMO Manufacturing Hub In Japan To Strengthen Asia Biologics Supply

FUJIFILM Corporation  announced the completion of one of Japan’s largest bio CDMO facilities (the new plant) at the Toyama Second Factory ...

 December 30, 2025 | News

Japan Approves Sephience For All Ages Marking First PTC Product Clearance In The Country

– Indication includes all ages and the full spectrum of disease severity –– First Japan product approval for PTC – PTC T...

 December 30, 2025 | News

Italfarmaco Partners With JCR Pharmaceuticals To Advance Givinostat Development And Commercialisation In Japan

Italfarmaco grants JCR Pharmaceuticals exclusive rights to develop and commercialise givinostat in Japan - - Additional strategic collaboration in rare ...

 December 25, 2025 | News

Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...

 December 23, 2025 | News

Japanese Skincare Brand Yii Partners With ANDS Corporation To Bring Pharmaceutical Grade Science To Sensitive Skin

Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the nic...

 December 23, 2025 | News

CHITOSE And FUJIFILM Biosciences Form Strategic Alliance To Advance Biopharmaceutical Manufacturing

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media. Ch...

 December 22, 2025 | News

Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation

-Meiji Seika Pharma Co., Ltd.  announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...

 December 22, 2025 | News

PeptiDream Advances Oral Dual IL17 Inhibitor Into Clinical Development Portfolio

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) a...

 December 19, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close